Adagio Medical Holdings (ADGM) Income from Continuing Operations (2023 - 2026)
Adagio Medical Holdings (ADGM) posted Income from Continuing Operations of 6804000.0 for Q1 2026, down 47.56% sequentially from 4611000.0 in Q4 2025, and up 26.34% YoY from 5385479.69 in Q1 2025.
Adagio Medical Holdings (ADGM) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Adagio Medical Holdings has reported Income from Continuing Operations for 4 years, with the latest figure at 6804000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 26.34% year-over-year to 6804000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28036000.0 (up 50.4% YoY) and the FY2025 annual result came in at 62613000.0, up 0.87% from the prior year.
- Income from Continuing Operations slipped to 6804000.0 in Q1 2026 per ADGM's latest filing, from 4611000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 4611000.0 in Q4 2025 and troughed at 32957000.0 in Q2 2024.
- A 4-year average of 10051200.0 and a median of 8020500.0 in 2025 frame the typical range for Income from Continuing Operations.
- The widest YoY moves for Income from Continuing Operations: up 83.81% in 2025, down 137.15% in 2025.
- Over 4 years, Income from Continuing Operations stood at 6391000.0 in 2023, then rose by 25.54% to 4759000.0 in 2024, then advanced by 3.11% to 4611000.0 in 2025, then tumbled by 47.56% to 6804000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 6804000.0, 4611000.0, and 11286000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Adagio Medical Holdings | 14.43 Mn | 14.43 Mn | - | -5.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.23 Mn |
| Mar 31, 2026 | -6.80 Mn |
| Dec 31, 2025 | -4.61 Mn |
| Sep 30, 2025 | -11.29 Mn |
| Jun 30, 2025 | -5.34 Mn |
| Mar 31, 2025 | -9.24 Mn |
| Sep 30, 2024 | -4.76 Mn |
| Jun 30, 2024 | -32.96 Mn |
| Mar 31, 2024 | -9.57 Mn |
| Dec 31, 2023 | -6.39 Mn |
| Sep 30, 2023 | -9.56 Mn |